Arrhythmogenic right ventricular dysplasia, or ARVD — also known as arrhythmogenic right ventricular cardiomyopathy, or ARVC — is a genetic condition (autosomal dominant) affecting the desmosomes of ... Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is an inheritable myocardial disorder characterised by the progressive replacement of cardiac muscle with fibrofatty tissue. This structural ...
Leuven, Belgium - Participating in high-intensity endurance sports may predispose athletes to ventricular arrhythmias and mild right ventricular (RV) dysfunction, raising the possibility that ... High-level endurance athletes with ventricular tachycardia (VT) may have unique scarring in the right ventricular outflow tract (RVOT) that acts as a substrate for the arrhythmia, a new study shows. Nasdaq: Tenaya Therapeutics Announces Interim Findings from RIDGE Study, the Largest Natural History Study of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Tenaya Therapeutics has announced interim data from its RIDGE natural history study, the largest research effort to date on arrhythmogenic right ventricular cardiomyopathy (ARVC) associated with ... Tenaya Therapeutics Announces Interim Findings from RIDGE Study, the Largest Natural History Study of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Arrhythmogenic right ventricular dysplasia/cardiomyopathy was first reported as the partial replacement of the right ventricular myocardium by fat or fibrous tissue.
